Intensity Therapeutics Common Stock Technical Analysis
| INTS Stock | 0.40 0.01 2.44% |
As of the 23rd of January, Intensity Therapeutics retains the Risk Adjusted Performance of 0.0801, downside deviation of 11.66, and Market Risk Adjusted Performance of (14.41). Intensity Therapeutics technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices. Please check out Intensity Therapeutics information ratio and downside variance to decide if Intensity Therapeutics is priced fairly, providing market reflects its last-minute price of 0.4 per share. As Intensity Therapeutics is a penny stock we also advise to confirm its total risk alpha numbers.
Intensity Therapeutics Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Intensity, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to IntensityIntensity | Build AI portfolio with Intensity Stock |
Intensity Therapeutics Analyst Consensus
| Target Price | Advice | # of Analysts | |
| 2.92 | Buy | 5 | Odds |
Most Intensity analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Intensity stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Intensity Therapeutics, talking to its executives and customers, or listening to Intensity conference calls.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Intensity Therapeutics. If investors know Intensity will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Intensity Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Intensity Therapeutics is measured differently than its book value, which is the value of Intensity that is recorded on the company's balance sheet. Investors also form their own opinion of Intensity Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Intensity Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Intensity Therapeutics' market value can be influenced by many factors that don't directly affect Intensity Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Intensity Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Intensity Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Intensity Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Intensity Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Intensity Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Intensity Therapeutics.
| 10/25/2025 |
| 01/23/2026 |
If you would invest 0.00 in Intensity Therapeutics on October 25, 2025 and sell it all today you would earn a total of 0.00 from holding Intensity Therapeutics Common or generate 0.0% return on investment in Intensity Therapeutics over 90 days. Intensity Therapeutics is related to or competes with Iterum Therapeutics, Rallybio Corp, IBio Common, Pluri, Boundless Bio, Plus Therapeutics, and NextCure. Intensity Therapeutics is entity of United States More
Intensity Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Intensity Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Intensity Therapeutics Common upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 11.66 | |||
| Information Ratio | 0.093 | |||
| Maximum Drawdown | 433.59 | |||
| Value At Risk | (14.04) | |||
| Potential Upside | 12.2 |
Intensity Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Intensity Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Intensity Therapeutics' standard deviation. In reality, there are many statistical measures that can use Intensity Therapeutics historical prices to predict the future Intensity Therapeutics' volatility.| Risk Adjusted Performance | 0.0801 | |||
| Jensen Alpha | 4.67 | |||
| Total Risk Alpha | (1.59) | |||
| Sortino Ratio | 0.3901 | |||
| Treynor Ratio | (14.42) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Intensity Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Intensity Therapeutics January 23, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0801 | |||
| Market Risk Adjusted Performance | (14.41) | |||
| Mean Deviation | 13.77 | |||
| Semi Deviation | 8.7 | |||
| Downside Deviation | 11.66 | |||
| Coefficient Of Variation | 1051.61 | |||
| Standard Deviation | 48.94 | |||
| Variance | 2395.5 | |||
| Information Ratio | 0.093 | |||
| Jensen Alpha | 4.67 | |||
| Total Risk Alpha | (1.59) | |||
| Sortino Ratio | 0.3901 | |||
| Treynor Ratio | (14.42) | |||
| Maximum Drawdown | 433.59 | |||
| Value At Risk | (14.04) | |||
| Potential Upside | 12.2 | |||
| Downside Variance | 136.02 | |||
| Semi Variance | 75.77 | |||
| Expected Short fall | (23.86) | |||
| Skewness | 7.65 | |||
| Kurtosis | 60.97 |
Intensity Therapeutics Backtested Returns
Intensity Therapeutics is out of control given 3 months investment horizon. Intensity Therapeutics holds Efficiency (Sharpe) Ratio of 0.1, which attests that the entity had a 0.1 % return per unit of risk over the last 3 months. We were able to interpolate and analyze data for twenty-eight different technical indicators, which can help you to evaluate if expected returns of 5.23% are justified by taking the suggested risk. Use Intensity Therapeutics Common Risk Adjusted Performance of 0.0801, market risk adjusted performance of (14.41), and Downside Deviation of 11.66 to evaluate company specific risk that cannot be diversified away. Intensity Therapeutics holds a performance score of 8 on a scale of zero to a hundred. The company retains a Market Volatility (i.e., Beta) of -0.32, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Intensity Therapeutics are expected to decrease at a much lower rate. During the bear market, Intensity Therapeutics is likely to outperform the market. Use Intensity Therapeutics Common total risk alpha, downside variance, as well as the relationship between the Downside Variance and daily balance of power , to analyze future returns on Intensity Therapeutics Common.
Auto-correlation | -0.14 |
Insignificant reverse predictability
Intensity Therapeutics Common has insignificant reverse predictability. Overlapping area represents the amount of predictability between Intensity Therapeutics time series from 25th of October 2025 to 9th of December 2025 and 9th of December 2025 to 23rd of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Intensity Therapeutics price movement. The serial correlation of -0.14 indicates that less than 14.0% of current Intensity Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.14 | |
| Spearman Rank Test | 0.45 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Intensity Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Intensity Therapeutics Technical Analysis
The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Intensity Therapeutics volatility. High ATR values indicate high volatility, and low values indicate low volatility.
About Intensity Therapeutics Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Intensity Therapeutics Common on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Intensity Therapeutics Common based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Intensity Therapeutics price pattern first instead of the macroeconomic environment surrounding Intensity Therapeutics. By analyzing Intensity Therapeutics's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Intensity Therapeutics's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Intensity Therapeutics specific price patterns or momentum indicators. Please read more on our technical analysis page.
Intensity Therapeutics January 23, 2026 Technical Indicators
Most technical analysis of Intensity help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Intensity from various momentum indicators to cycle indicators. When you analyze Intensity charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0801 | |||
| Market Risk Adjusted Performance | (14.41) | |||
| Mean Deviation | 13.77 | |||
| Semi Deviation | 8.7 | |||
| Downside Deviation | 11.66 | |||
| Coefficient Of Variation | 1051.61 | |||
| Standard Deviation | 48.94 | |||
| Variance | 2395.5 | |||
| Information Ratio | 0.093 | |||
| Jensen Alpha | 4.67 | |||
| Total Risk Alpha | (1.59) | |||
| Sortino Ratio | 0.3901 | |||
| Treynor Ratio | (14.42) | |||
| Maximum Drawdown | 433.59 | |||
| Value At Risk | (14.04) | |||
| Potential Upside | 12.2 | |||
| Downside Variance | 136.02 | |||
| Semi Variance | 75.77 | |||
| Expected Short fall | (23.86) | |||
| Skewness | 7.65 | |||
| Kurtosis | 60.97 |
Intensity Therapeutics January 23, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Intensity stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 24,887 | ||
| Daily Balance Of Power | (1.00) | ||
| Rate Of Daily Change | 0.98 | ||
| Day Median Price | 0.40 | ||
| Day Typical Price | 0.40 | ||
| Price Action Indicator | 0.00 |
Additional Tools for Intensity Stock Analysis
When running Intensity Therapeutics' price analysis, check to measure Intensity Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Intensity Therapeutics is operating at the current time. Most of Intensity Therapeutics' value examination focuses on studying past and present price action to predict the probability of Intensity Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Intensity Therapeutics' price. Additionally, you may evaluate how the addition of Intensity Therapeutics to your portfolios can decrease your overall portfolio volatility.